GREENFIELD, Ind., May 5, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the sale of certain future tiered royalties and commercial milestones associated with XDEMVY® (lotilaner ophthalmic solution) 0.25%, for the human health application of lotilaner,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown )
Also on site :
- Anne Burrell's Husband Looks Somber in First Photo Since Food Network Star's Death
- Iran threatens US bases in Middle East, asserts nuclear facilities undamaged
- Trump’s Gulf Arab allies race to avoid all-out war in Iran